Trial
NCT03592407
Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Esophageal Squamous Cell Carcinoma
Intervention
Epacadostat
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-08